Costs and benefits of targeted screening for causes of sudden cardiac death in children and adolescents
about
Attention-Deficit Hyperactivity Disorder and Long-QT Syndrome: Risky BusinessAttention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?Spatial/Frontal QRS-T Angle Predicts All-Cause Mortality and Cardiac Mortality: A Meta-AnalysisSurvey of United States child and adolescent psychiatrists' cardiac screening practices prior to starting patients on stimulantsCARDIOVASCULAR SCREENING OF YOUNG ATHLETES: A REVIEW OF ECONOMIC EVALUATIONS.Value-Based Insurance Design: Aligning Incentives to Improve Cardiovascular Care.Sudden Cardiac Death in the YoungPrediction and prevention of sudden death in young populations: the role of ECG screening.Sports preparticipation cardiac screening: what about children?Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE.Implementation of ultraportable echocardiography in an adolescent sudden cardiac arrest screening program.Electrocardiographic screening for hypertrophic cardiomyopathy and long QT syndrome: the drivers of cost-effectiveness for the prevention of sudden cardiac death.Prevention of sudden death in adolescent athletes: Incremental diagnostic value and cost-effectiveness of diagnostic tests.The psychological impact of cardiovascular screening: the athlete's perspective.Electrocardiogram before starting stimulant medications: to order or not?Prevention of Sudden Cardiac Death in Children and Young Adults.Cardiac Screening of Young Athletes: a Practical Approach to Sudden Cardiac Death PreventionPre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE
P2860
Q33165891-372DEFA8-8C35-4795-86DF-E441E13B547CQ34461113-2FE66215-52EF-4FC6-8AEC-9E2BEC99F9A9Q35748799-E34CFB8E-071D-4147-8017-49E6854E4DA6Q36351008-9F626A68-A890-4B16-AB7F-611430D17A74Q36354847-369AD290-399C-499A-80C5-E76F58F3A955Q37167826-E120FEAB-8EC9-4D4A-93B7-AB910E748166Q37275861-5DF3D9D2-A27B-4A6E-B8AD-897B8E62A976Q38062432-BE34D9AB-3B90-4C06-B4C2-5892CE43578CQ38115208-540FAA57-330C-4234-99E6-EAD5711D7DC4Q40488679-CF8C03FD-A790-4C27-A048-5B4CA88133DAQ42904630-5138E7FB-61AD-4224-A822-B115B163A2ECQ44680690-332950D1-80A6-4DBB-9F95-AAA76A6F9563Q47339260-B09B9FFC-4A7B-4638-B7B1-507376AC5ECEQ47876265-2EBEF047-9981-4520-89F6-5B9BED4E8F8FQ48028010-E0976520-3ABE-4FBF-9A38-BD33C0E85428Q50066035-77B738A1-07D6-42AB-B06D-00FCDEE98CC6Q58697683-FD86B720-D0B0-4E03-A740-27EE1189CC26Q58757143-656DF56A-6FB9-42B6-A944-A2DC05177E8F
P2860
Costs and benefits of targeted screening for causes of sudden cardiac death in children and adolescents
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Costs and benefits of targeted ...... th in children and adolescents
@ast
Costs and benefits of targeted ...... th in children and adolescents
@en
type
label
Costs and benefits of targeted ...... th in children and adolescents
@ast
Costs and benefits of targeted ...... th in children and adolescents
@en
prefLabel
Costs and benefits of targeted ...... th in children and adolescents
@ast
Costs and benefits of targeted ...... th in children and adolescents
@en
P2093
P2860
P1433
P1476
Costs and benefits of targeted ...... th in children and adolescents
@en
P2093
Angie Mae Rodday
Elizabeth D Sherwin
John B Wong
John K Triedman
Joshua T Cohen
Laurel K Leslie
Mark E Alexander
Susan K Parsons
P2860
P304
P356
10.1161/CIRCULATIONAHA.111.087940
P407
P577
2012-05-03T00:00:00Z